Methacrylic Acid

Methacrylic Acid

SCHEMBL3949680

C=C(C)C(=O)O.NC(=O)NCc1ccccc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.53
CYP2C19 P33261 2/20 0.51
RECQL P46063 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
PTPN1 P18031 1/20 0.47
GAA P10253 1/20 0.47
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
MAPT P10636 2/20 0.46
RIPK1 Q13546 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
EPHX1 P07099 1/20 0.45
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL81511 0.87 CYP2C19 (0.64) CYP2C9CYP2C19RECQLCYP1A2CYP2D6
Urea SCHEMBL11221937 0.85 CYP2C19 (0.62) CYP2C9CYP2C19RECQLCYP1A2CYP2D6
Ammonia Solution, Strong SCHEMBL5961420 0.85 CYP2C19 (0.62) CYP2C9CYP2C19RECQLCYP1A2CYP2D6
Benzene SCHEMBL3802036 0.85 CYP2C19 (0.62) CYP2C9CYP2C19RECQLCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL17710406 0.85 CYP2C19 (0.62) CYP2C9CYP2C19RECQLCYP1A2CYP2D6
Methacrylic Acid SCHEMBL28898117 0.84 ALDH1A1 (0.56) CYP2C9SMN1; SMN2PTPN1GAAALDH1A1
Dimethylamine SCHEMBL28098755 0.84 CYP2C9 (0.56) CYP2C9CYP2C19RECQLCYP1A2CYP2D6
Acrylic Acid SCHEMBL3948526 0.81 CYP2C19 (0.54) CYP2C9CYP2C19RECQLCYP1A2CYP2D6
N-Benzylmethylamine SCHEMBL27722064 0.80 MAPT (0.63) CYP2C9SMN1; SMN2PTPN1GAAALDH1A1
SCHEMBL183463 0.80 ALDH1A1 (0.59) CYP2C9SMN1; SMN2PTPN1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7498394-B2 (Meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2009-03-03 US disclosed
US-20060252900-A1 (Meth)arcrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained REGENTS OF THE UNIVERSITY OF COLORADO, THE 2006-11-09 US disclosed
WO-2004077511-A2 (METH)ACRYLIC AND (METH)ACRYLAMIDE MONOMERS, POLYMERIZABLE COMPOSITIONS, AND POLYMERS OBTAINED THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2004-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252900-A1 (Meth)arcrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained MMAB, MAT1A, MAT2A CYP2C9 2438/4885CYP2C19 2840/4885RECQL 2952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.